IL17A and Alzheimer disease: Compared with intact or saline-treated rats, AD animals displayed a significant upregulation of IL-17 and IL-22 mRNA and protein expression in the hippocampus and a remarkable elevation of IL-17 and IL-22 titers in the CSF and serum (Fig. 3).